Skip to content

MDMA research published in 2023

Page 6 of 7: studies 101 to 120 of 125, newest first. Back to the MDMA overview

Studies

Aromatic Bromination Abolishes Deficits in Visuospatial Learning Induced by MDMA (“Ecstasy”) in Rats While Preserving the Ability to Increase LTP in the Prefrontal Cortex

International Journal of Molecular Sciences February 13, 2023 Patricio Sáez-briones, Boris Palma, Héctor Burgos et al. 1 citation

It has recently been demonstrated that aromatic bromination at C(2) abolishes all typical psychomotor, and some key prosocial effects of the entactogen MDMA in rats. Nevertheless, the influence of aromatic bromination on MDMA-like effects on higher cognitive functions remains unexplored. In the present work, the effects of MDMA and its brominated analog 2Br-4,5-MDMA (1 mg/kg and 10 mg/kg i.p....

DOI: 10.3390/ijms24043724 (opens in new tab) MDMA Ecstasy Long-term potentiation Prefrontal cortex +4

Examining associations between MDMA/ecstasy and classic psychedelic use and impairments in social functioning in a U.S. adult sample

Scientific Reports February 11, 2023 Grant Jones, Joshua Lipson, Erica Wang 2 citations

Abstract Impairment in social functioning is a common source of morbidity across many mental health disorders, yet there is a dearth of effective and easily implemented interventions to support social functioning. MDMA/ecstasy and classic psychedelics (psilocybin, LSD, peyote, mescaline) represent two potential treatments for impairments in social functioning, as evidence suggests these...

Pilot study suggests DNA methylation of the glucocorticoid receptor gene (NR3C1) is associated with MDMA-assisted therapy treatment response for severe PTSD

Frontiers in Psychiatry February 6, 2023 Candace R. Lewis, Joseph Tafur, Sophie Spencer et al. 29 citations

BackgroundPrevious research has demonstrated that epigenetic changes in specific hypothalamic-pituitary-adrenal (HPA) genes may predict successful psychotherapy in post-traumatic stress disorder (PTSD). A recent Phase 3 clinical trial reported high efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy for treating patients with severe PTSD compared to a therapy with placebo...

Hofmann vs. Paracelsus: Do Psychedelics Defy the Basics of Toxicology?—A Systematic Review of the Main Ergolamines, Simple Tryptamines, and Phenylethylamines

Toxics February 3, 2023 Luis Alberto Henríquez-Hernández, Jaime Rojas-Hernández, Domingo Jesús Quintana Hernández et al. 21 citations

Psychedelics are experiencing a strong renaissance and will soon be incorporated into clinical practice. However, there is uncertainty about how much harm they can cause at what doses. This review aimed to collect information on the health-hazardous doses of psychedelic substances, to be aware of the risks to which patients may be subjected. We focused on ergolamines, simple tryptamines, and...

Plant Medicine Healing! Discovering the Roots of Psychedelic-Assisted Therapy in Mental Health

Advances in Research January 30, 2023 Jennings Hernandez

Roughly over 700 million individuals suffer from a mental illness globally. In the United States alone, over 45 million individuals are afflicted with a mental disorder at any given point in their lives. It is because of this that new methods of current therapies should be considered. To date, major depression disorder (MAD), anxiety, and post-traumatic stress disorder (PTSD) are treated with...

Substance Use and Attendance Motives of Electronic Dance Music (EDM) Event Attendees: A Survey Study

International Journal of Environmental Research and Public Health January 19, 2023 Koen Ponnet, Bert Hauspie, Nicky Dirkx et al. 21 citations

EDM event attendees are a high-risk population for substance use and associated adverse effects. The aim of this study was to examine substance use at EDM events, focusing on associations between attendance motives and substance use. Sociodemographic characteristics, event specifics, past-year use, and attendance motives were assessed through an online survey. Participants were 1345 Belgian EDM...

DOI: 10.3390/ijerph20031821 (opens in new tab) Ecstasy Cannabis Electronic dance music Attendance +1

Journey To The Centre Of The Mind: Psychedelic Treatment of Mental Health in Aotearoa

January 16, 2023 Daisy Lutyens 1 citation

<p>Examining participants’ experiences self-medicating with LSD, psilocybin, and MDMA, this exploratory study sought to determine whether psychedelics have a future in New Zealand mental health treatment. This thesis employed a mixed-methods approach to data collection, by collecting broad-brush quantitative data via a Qualtrics survey, which then informed the qualitative data collection method...

Psychedelics for Patients With Cancer: A Comprehensive Literature Review

Annals of Pharmacotherapy January 12, 2023 C Michael White, Nissen Weisman, Joseph Dalo 18 citations

Objective: To assess the role of psychedelics in the treatment of anxiety or depression among patients with cancer. Data Sources: PubMed search from inception to March 11, 2022, using the terms anxiety, depression, psychedelics, psilocybin, lysergic acid, methylenedioxymethamphetamine, or ayahuasca. Study Selection and Data Extraction: Studies assessing patients with cancer receiving...

Self-experience in MDMA assisted therapy of PTSD

medRxiv Preprint Server January 3, 2023 Bessel Van der Kolk, Julie B. Wang, Rachel Yehuda et al. 2 citations preprint

In recent years there has been a resurgence of interest in the therapeutic potential of psychedelic substances such as 3,4-methylenedioxymethamphetamine (MDMA). This renaissance of psychedelic studies opens the door for a new paradigm in psychiatric medicine: drug-facilitated psychotherapy. In this study we report the findings of a randomized, double-blind, placebo-controlled, multi-site Phase...

What Do Young Adults Expect from the Recreational Use of Ecstasy (3,4-Methylenedioxymethamphetamine/Molly)? A Latent Class Analysis of a Convenience Sample of Dutch Young Adults

European Addiction Research 2023 Martha Charlotta De Jonge, Andrea Johanna Bukman, Tom F. M. Ter Bogt et al.

Introduction: This study offers insights into Dutch young people’s expected social and personal consequences of ecstasy use. Substance use expectancies are assumed to be an essential component in explaining substance use behaviour and, therefore, the development of effective substance use prevention and treatment strategies. Method: Dutch young adults with an online interest in drug-related...

Efectos positivos en el ámbito social de la administración controlada de MDMA

2023 Ovidio Baquero Ramírez, Ariel Enrique Pastrana Arias

La 3,4-metilendioximetanfetamina (MDMA) se clasifica como un entactógeno que produce sentimientos de apertura emocional y relación. Una característica única de la MDMA es que las personas tienden a tomar esta droga de manera selectiva en situaciones sociales y/o íntimas. Aunque se reconoce que la MDMA tiene riesgo de abuso, los estudios preclínicos informan que tiene efectos de refuerzo débiles...

Amphetamine-type Stimulants: Novel Insights into their Actions and use Patterns.

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 2023 Miguel I Paz-Ramos, Silvia L. Cruz, Valeria Violante-Soria

This review focuses on the effects and mechanisms of action of amphetamine-type stimulants (ATS) and their adverse effects on the cardiovascular, nervous, and immune systems. ATS include amphetamine (AMPH), methamphetamine (METH, "crystalmeth," or "ice"), methylenedioxymethamphetamine (MDMA, "ecstasy," or "Molly"), MDMA derivatives (e.g., methylenedioxyamphetamine [MDA] and...

Development and initial validation of an MDMA/Ecstasy motives assessment.

Addictive Behaviors 2023 James E Sottile, Kathryn S Macia, Robert E Wickham et al.

MDMA/Ecstasy motives differ from those of other substances such as alcohol, cannabis, and methamphetamine. Previous literature on alcohol and cannabis use identified social, expansion, enhancement, coping, and conformism as primary motives for use. MDMA/Ecstasy users also report using the drug for increases in self-awareness and energy. The development of an MDMA/Ecstasy use motives assessment...

Disorders due to Substance Use: Hallucinogens and MDMA-Related Substances

Tasman’s Psychiatry 2023 Sandeep M. Nayak, Matthew W. Johnson

Hallucinogens are a broad category of substances encompassing drugs with diverse pharmacological, phenomenological, and adverse effects. In this chapter, the focus is on disorders caused by and exacerbated by two classes of hallucinogens. These are classic psychedelics (drugs including LSD and psilocybin that exert subjective effects principally by 5HT_2A agonism) and the substituted...

Enhancing Fear Extinction: Pharmacological Approaches

Fear Extinction 2023 Olga Y. Ponomareva, Robert J. Fenster, Kerry J. Ressler

Extinction is the process by which the memory of a learned conditioned association decreases over time and with introduction of new associations. It is a vital part of fear learning, and it is critical to recovery in multiple fear-related disorders, including Specific and Social Phobias, Panic Disorder, Obsessive Compulsive Disorder (OCD), and Posttraumatic Stress Disorder (PTSD). The process...

MDMA-assisted psychotherapy with adolescents suffering from PTSD: Do or don’t? a qualitative study with youth, parents, and clinicians

Drug Science, Policy and Law 2023 Anoek S Van Vugt, Josjan Zijlmans, Ramon Lindauer et al. 2 citations

Background PTSD in adolescence causes much suffering and has substantial health-care costs. Many patients with severe PTSD do not respond to psychotherapy or continue to have symptoms despite trauma-focused psychotherapies and psychopharmacological treatment. A recent alternative in the search for cost-effective treatments for PTSD in adults is 3,4-methylenedioxymethamphetamine-assisted...

MDMA-assisted psychotherapy in the treatment of PTSD in adults – literature review

Pharmacotherapy in Psychiatry and Neurology 2023 Monika Nowak, Julia Górczyńska, Michał Gebuza

AMA Nowak M, Górczyńska J, Gebuza M. MDMA-assisted psychotherapy in the treatment of PTSD in adults – literature review. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii. 2023;39(2):131-142. doi:10.5114/fpn.2023.133519. APA Nowak, M., Górczyńska, J., & Gebuza, M. (2023). MDMA-assisted psychotherapy in the treatment of PTSD in adults – literature review....

The Psychedelic Renaissance in Clinical Research: A Bibliometric Analysis of Three Decades of Human Studies with Psychedelics.

Journal of Psychoactive Drugs 2023 Aviad Hadar, Jonathan David, Nadav Shalit et al. 93 citations

Psychedelics were used in the treatment of psychiatric conditions prior to their prohibition in the late 1960s. In the past three decades, there is a revived research interest in the therapeutic potential of psychedelic drugs with expected FDA approvals for treatment of various conditions. Given the exponential scientific growth of this field, we sought to characterize, analyze, and visualize...

Perceived key change phenomena of MDMA-assisted psychotherapy for the treatment of severe PTSD: an interpretative phenomenological analysis of clinical integration sessions.

Frontiers in Psychiatry 2023 Macha Godes, Jasper Lucas, Eric Vermetten 14 citations

Post-traumatic stress disorder (PTSD) is a prevalent psychiatric condition that significantly impacts daily functioning in patients but lacks adequate treatment options. 3,4-methylenedioxymethamphetamine (MDMA) as an adjunct to psychotherapy for the treatment of PTSD has been studied increasingly for the last two decades and has shown promising results through quantitative data. However, few...

DOI: 10.3389/fpsyt.2023.957824 (opens in new tab) Full text (opens in new tab) PTSD MDMA-Assisted Psychotherapy Interpretative phenomenological analyses Psychedelics +1

Women and MDMA: particularities of gender and sex.

International Review of Psychiatry 2023 Fabio Carezzato, Ilana Falcão de Arruda, Caio Petrus Monteiro Figueiredo et al. 4 citations

This comprehensive review delves into the intricate interplay between gender/sex and MDMA use, drawing upon recent evidence. It explores how girls, as a means of coping with negative emotions, often resort to drug use, while boys primarily initiate drug use due to peer pressure or sensation-seeking tendencies. Women, frequently having endured traumatic life events, may turn to MDMA as a form of...